Publication of SARA-INT Phase II results for BIO101Confirmation of Phase 3 readinessParis, France and Cambridge, Massachusetts--(Newsfile Corp. - March 17, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis ...
Sarcopenia influences toxicity and survival in non-small cell lung cancer, and sarcopenia assessment can be factored into ...
While a gradual loss in muscle strength is a natural part of aging, for many older adults it’s more than just feeling a ...
Researchers enhance sarcopenia treatment by analyzing gut bacteria and genetics Personalized strategies are essential for ...
A new study suggests that a small molecule drug that targets a specific serotonin receptor could become the first ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
11d
The "Sarcopenia - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers an in-depth analysis of the current developments and future prospects in the ...
Allosteric Bioscience, Inc. (ABI), has announced today that it has licensed technology from Johns Hopkins University for the treatment or prevention of sarcopenia which is a serious medical ...
While a gradual loss in muscle strength is a natural part of aging, for many older adults it's more than just feeling a little weaker. Sarcopenia -- a condition affecting nearly half of adults over 80 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback